National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

The National Cancer Institute is seeking research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions. The proposed project must involve at least 1 clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program, and/or the HIV and AIDS Malignancies Research Programs. • The opportunity is open to various types of applicants, including small businesses, special district governments, state governments, private institutions of higher education, and non-profits. • The estimated funding for this opportunity is $499,999. • The opportunity is focused on cancer treatment and diagnosis research. • Applicants must propose to conduct an early phase trial by itself, or in combination with another research aim(s) as appropriate. • The opportunity is a grant, and the funding instrument is a grant. • The opportunity is related to the education and health funding activity categories.